Marquette University

e-Publications@Marquette
Biological Sciences Faculty Research and
Publications

Biological Sciences, Department of

5-1-2013

Roles of Predicted Glycosyltransferases in the
Biosynthesis of the Rhizobium etli CE3 O Antigen
Kristylea J. Ojeda
Dominican University of California

Laurie Simonds
K. Dale Noel
Marquette University, dale.noel@marquette.edu

Published version. Journal of Bacteriology, Vol. 195, No. 9 (May 2013): 1949-1958. DOI. © 2013
American Society of Microbiology. Used with permission.

Roles of Predicted Glycosyltransferases in the Biosynthesis of the
Rhizobium etli CE3 O Antigen
Kristylea J. Ojeda,* Laurie Simonds, K. Dale Noel
Department of Biological Sciences, Marquette University, Milwaukee, Wisconsin, USA

L

ipopolysaccharide (LPS) is the major surface component of
Gram-negative bacteria and consists of lipid A, a core oligosaccharide, and an O-specific polysaccharide or O antigen (1).
While the composition, structure, and synthesis of lipid A and
core regions are often similar, especially between closely related
species, the O-antigen portions can vary considerably even between strains of the same species (1, 2). O antigens can consist of a
polymer of a single sugar (homopolymer) or many different sugars (heteropolymer). In both types of polymers, the number of
repeating units can be either fixed or varied, giving rise to O antigens of uniform and modal lengths, respectively (1, 2).
Further variation occurs due to the fact that a given O antigen
is synthesized by one of two main types of pathways, one dependent on Wzy polymerase and the other involving an ATP-binding
cassette (ABC) transporter (1). In each pathway, the initial reaction attaches a sugar-phosphate to bactoprenol phosphate (BpP),
creating the first in a series of pyrophosphoryl-bactoprenol-linked
(BpPP) oligosaccharide intermediates (3–5). O-antigen biosynthesis by the Wzy pathway assembles on the cytoplasmic face of
the inner membrane a single repeating unit on BpPP, which is
then “flipped” across the inner membrane by protein Wzx. In the
periplasm, a growing O-antigen chain on another BpPP is transferred, through the action of an O-antigen polymerase encoded by
wzy, to the nonreducing end of the newly “flipped” repeating unit.
Thus, elongation of the O antigen occurs by extension at the reducing end in this type of O-antigen synthesis, like peptidoglycan
synthesis. In contrast, O-antigen biosynthesis by the ABC transporter pathway assembles the complete O antigen on BpPP at the
cytoplasmic face of the inner membrane. The subsequent glycosyltransferase reactions elongate the O antigen by the addition of
sugars at the nonreducing end (6). An ABC transporter, typically
composed of subunits Wzm and Wzt (7, 8), translocates the completed O-antigen-BpPP intermediate to the periplasmic face of the
inner membrane. Both pathways converge again at the point when
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the O antigen is ligated to the lipid A-core regions (9, 10), and the
mature LPS is transported to the outer membrane (11, 12).
The O-antigen portion of the Rhizobium etli CE3 LPS is a heteropolymer of uniform length, most molecules having five repeats of
a three-sugar unit (Fig. 1) (13). Having homologs of wzm and wzt in
the chromosomal O-antigen genetic cluster (Fig. 2), R. etli CE3 is
postulated to synthesize its O antigen by the ABC transporter pathway (2, 14, 15). For this type of synthesis, the terms primer, adaptor,
repeat-unit domain, and chain terminator have been proposed for
different portions of the O-chain (1, 4), as indicated in Fig. 1. Based
on considerations discussed below, it is likely that the primer sugar of
the CE3 O antigen is 2-N-acetamido-2,6-dideoxyglucose (N-acetylquinovosamine [QuiNAc]). Attached to the primer are the four sugars of the adaptor region, which are defined here as sugars added
through the action of glycosyltransferases that act once per O antigen.
In strain CE3, mannose and the first fucose (FucI) are obvious components of the adaptor region, but perhaps less obvious are two sugars in the first instance of the repeat unit. One of these latter two
sugars is a fucose (FucII), which is attached to FucI, whereas the remaining repeat-unit fucoses (FucIII-VI) are attached to methyl glucuronate (MeGlcA). Therefore, the enzyme that catalyzes the addition
of FucII should act only once. The last sugar of the adaptor, either a
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The Rhizobium etli CE3 O antigen is a fixed-length heteropolymer. The genetic regions required for its synthesis have been identified,
and the nucleotide sequences are known. The structure of the O antigen has been determined, but the roles of specific genes in synthesizing this structure are relatively unclear. Within the known O-antigen genetic clusters of this strain, nine open reading frames (ORFs)
were found to contain a conserved glycosyltransferase domain. Each ORF was mutated, and the resulting mutant lipopolysaccharide
(LPS) was analyzed. Tricine SDS-PAGE revealed stepwise truncations of the O antigen that were consistent with differences in mutant
LPS sugar compositions and reactivity with O-antigen-specific monoclonal antibodies. Based on these results and current theories of
O-antigen synthesis, specific roles were deduced for each of the nine glycosyltransferases, and a model for biosynthesis of the R. etli
CE3 O antigen was proposed. In this model, O-antigen biosynthesis is initiated with the addition of N-acetyl-quinovosamine-phosphate (QuiNAc-P) to bactoprenol-phosphate by glycosyltransferase WreU. Glycosyltransferases WreG, WreE, WreS, and WreT would
each act once to attach mannose, fucose, a second fucose, and 3-O-methyl-6-deoxytalose (3OMe6dTal), respectively. WreH would then
catalyze the addition of methyl glucuronate (MeGlcA) to complete the first instance of the O-antigen repeat unit. Four subsequent repeats of this unit composed of fucose, 3OMe6dTal, and MeGlcA would be assembled by a cycle of reactions catalyzed by two additional
glycosyltransferases, WreM and WreL, along with WreH. Finally, the O antigen would be capped by attachment of di- or tri-O-methylated fucose as catalyzed by glycosyltransferase WreB.
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MeGlcA or 3-O-methyl-6-deoxytalose (3OMe6dTal), is also added
to an L-fucose, but only to FucII and not to FucI (13). One way to
prevent its addition to FucI uses the fact that the responsible enzyme
acts on the acceptor substrate only if it ends in two linked fucoses
(FucII-FucI-), which is true only at this point in the synthesis. An
enzyme with such a specificity should act only once in the formation
of an O-antigen chain. After completion of the four-sugar adaptor,
synthesis would then shift to three additional enzymes, which would
recognize portions of the acceptor substrate that repeatedly appear in
a cycle of three reactions resulting in the assembly of the complete
repeat-unit domain. A final enzyme would catalyze the addition of
the terminal residue, 2,3-di-O-methylfucose, which is variably
O-methylated at position 4. This model of CE3 O-antigen synthesis
predicts nine different glycosyltransferases.
Nearly all the genes required to synthesize the known R. etli
CE3 O-antigen structure are located in three separate loci in the
genome (2, 14, 16). Except for well-known orthologous genes,
such as fcl and gmd, genes devoted to R. etli CE3 O-antigen syn-

thesis have been given the designation wre (Fig. 2) (17) in order to
conform with the conventions of naming O-antigen-related genes
(18). (For example, genes in Fig. 2 designated fcl, gmd, wreE, wreU,
and wreV in various previous contexts have been referred to as
nolK, noeL, exoU, lps␤1, and lps␤2, respectively [14, 19].) Besides
genes for the ABC O-antigen transporter (15), the wre loci include
genes predicted to encode proteins for the synthesis of nucleotides
of O-antigen-specific sugars (2, 19–21). Also within two of these
loci are wre genes predicted to encode the glycosyltransferases
needed to connect together the sugars from these sugar nucleotides. The chromosomal genetic cluster contains eight open reading frames (ORFs) whose sequences are predicted to encode glycosyltransferases, and one such ORF is located on plasmid
pCFN42b (Fig. 2). One of these ORFs (wreB) has been shown to be
required for the addition of the terminal residue of the O antigen
(17). In this study, the LPSs from mutants defective in each of the
other predicted glycosyltransferase ORFs were analyzed. Each
ORF was shown to be required for O-antigen synthesis. From the

FIG 2 R. etli CE3 O-antigen genetic clusters encoding putative glycosyltransferases. (A) The R. etli CE3 chromosomal O-antigen genetic cluster spans nucleotides
784,527 to 812,262 of the genome sequence (14) and consists of 25 putative ORFs. (B) The O-antigen genetic cluster on plasmid pCFN42b spans nucleotides 277
to 4,328 (14) and consists of 3 putative ORFs. The predicted glycosyltransferases are enlarged, and other related ORFs are indicated. ORFs RHE_PB00001,
RHE_CH00748, RHE_CH00749, RHE_CH00755, RHE_CH00756, RHE_CH00757, RHE_CH00761, RHE_CH00764, and RHE_CH00766 were named wreU,
wreG, wreH, wreM, wreL, wreT, wreS, wreE, and wreB, respectively. The relative locations of mutations are indicated by white triangles for mutations created by
insertion of antibiotic cassettes and black triangles for mutations created by Tn5 mutagenesis. The strain numbers carrying these mutations are indicated above
or below the triangles.
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FIG 1 R. etli CE3 LPS I structure (13, 45). The O antigen is hypothesized to begin with N-acetyl-quinovosamine (QuiNAc) at the reducing end (see the text)
followed by mannose (Man) and fucose (Fuc) residues. After that are five repeats (in most molecules) of a unit consisting of Fuc, 3-O-methyl-6-deoxytalose
residue (3OMe6dTal), and methyl glucuronate (MeGlcA). One repeating unit is shown separately in order to emphasize that two of its residues are added by
glycosyltransferases that likely act only once and therefore belong to the biosynthetic adaptor region (see the text). Nonstoichiometric O-methylation occurs at
position 2 of the fucose (2OMeFuc) of the repeating units (not shown) (13, 35). The O-antigen backbone is capped with a 2,3-di-O-methylfucose terminal
residue that is variably O-methylated at position 4, as indicated by parentheses. O-antigen-specific sugars are shown in boldface type, and residues within the
primer, adaptor region, repeat-unit domain, and chain terminator are indicated. The structure of the core region, consisting of sugars 3-deoxy-D-manno-2octulonic acid (Kdo), galacturonic acid (GalA), mannose (Man), and galactose (Gal), is also shown.

Biosynthesis of the R. etli CE3 O Antigen

TABLE 1 Bacterial strains and plasmids used in this study
Description and/or genotype or phenotypea

Reference or source

Bacterial strains
R. etli strains
CE3
CE113
CE347
CE358
CE470
CE503
CE518
CE522
CE532
CE542
CE544
CE547
CE549
CE551
CE552
CE566
CE570

Wild-type strain; str-1
CE3 derivative; str-1 ⌬wreU
CE3 derivative; str-1 gmd::Tn5
CE3 derivative; str-1 wreG::Tn5
CE3 derivative; str-1 wreE::Km
CE3 derivative; str-1 wreB::Gm
CE3 derivative; str-1 wreL::Km
CE3 derivative; str-1 wreT::Km
CE3 derivative; str-1 lpcA::Km
CE3 derivative; str-1 wreM␤::Km
CE3 derivative; str-1 wreM␤::Gm
CE3 derivative; str-1 fcl::Km
CE3 derivative; str-1 fcl::Gm
CE3 derivative; str-1 wreS::Gm
CE3 derivative; str-1 wreS::Km
CE3 derivative; str-1 wreU::Km
CE3 derivative; str-1 wreH::Km

22
22
23
23
24
17
This work
This work
This work
17
17
This work
This work
This work
This work
This work
This work

F= endA1 recA1 hsdR17(rK⫺ mK⫹) supE44 thi-1 gyrA96 relA1 80lacZ⌬M15 ⌬(lacZYA-argF)U169 ⫺
endA1 recA1 gyrA96 thi hsdR17(rK⫺ mK⫹) relA1 supE44 ⌬(lac-proAB) [F= traD36 proAB lacIqZ⌬M15]
pro thi endA hsdR supE44 recA-J6 pRK2013Km::Tn9

Invitrogen
Promega
25

Suicide plasmid; Tcr oriT⫹ sacB⫹
aaC1 gene cassette; Gmr
nptII gene cassette; Kmr
nptII gene cassette; Kmr
fcl with Gm cassette inserted at SmaI site in pEX18Tc
fcl with Km cassette inserted at SmaI site in pEX18Tc
lpcA with Km cassette inserted at SalI site in pEX18Tc
wreH with Km cassette inserted at BamHI site in pEX18Tc
wreL with Gm cassette inserted at SmaI site in pEX18Tc
wreS with Km cassette inserted in EcoRV deletion in pEX18Tc
wreS with Gm cassette inserted in EcoRV deletion in pEX18Tc
wreT with Gm cassette inserted at XhoI site in pEX18Tc
wreU with Km cassette inserted in SalI deletion in pEX18Tc
Expression vector; Tcr

26
27
28
28
This work
This work
This work
This work
This work
This work
This work
This work
This work
29

E. coli strains
INV␣F=
JM109
MT616

Plasmids
pEX18Tc
pUCGm
pBSL15
pBSL86
pKT72
pKT73
pKT59
pLS15
pJB45
pKT81
pKT82
pJB47
pKT98
pFAJ1708

a
The str-1 gene confers resistance to streptomycin. Km, insertion of kanamycin resistance cassette from pBSL86 or pBSL15; Gm, insertion of gentamicin resistance cassette from
pUCGm.

LPS phenotypes, the encoded glycosyltransferases were assigned
particular roles in synthesis of the primer, adaptor, or repeat-unit
domains.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All Rhizobium etli strains (Table
1) were derived from strain CE3, which is itself a streptomycin-resistant
derivative (22) of wild-type strain CFN42, whose genome nucleotide sequence has been determined (14). R. etli strains were grown to stationary
phase at 30°C on a rotating shaker in TY liquid medium (0.5% tryptone
[Difco Laboratories], 0.3% yeast extract [Difco], and 10 mM CaCl2).
Escherichia coli strains were grown in Luria-Bertani (LB) liquid medium
(1.0% tryptone, 0.5% yeast extract, and 0.5% NaCl) to stationary phase at
37°C on a rotating shaker. Agar medium contained 1.5% Bacto agar
(Difco).
Computer analysis of predicted protein sequences. Amino acid sequences of open reading frames (ORFs) deduced from R. etli CE3
genomic DNA sequence (14) were compared to nonredundant (nr) pro-
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tein sequences by the BLAST search tool at the National Center for Biotechnology Information (NCBI) (30) and the Carbohydrate Active Enzyme (CAZy) database (http://www.cazy.org/). Alignment of amino acid
sequences was performed using ClustalW2, version 2.0.10.
Materials and techniques for DNA isolation. Genomic DNA was isolated from R. etli strains using the AquaPure genomic DNA isolation kit
(Bio-Rad) for use in cloning. E. coli JM109 (Promega) or INV␣F= (Invitrogen) competent cells were transformed (31), and plasmids were isolated
from E. coli using QIAprep spin miniprep (Qiagen). DNA was recovered
from agarose gels using Geneclean II kit (MP Biomedicals, LLC.) and
modified with restriction enzymes purchased from New England BioLabs
(NEB) (Beverly, MA). Custom primers were synthesized by Eurofins
MWG Operon (Huntsville, AL).
Cloning and site-directed mutagenesis. Using PCR, fcl, lpcA, wreH,
wreL, wreS, wreT, and wreU were amplified separately from R. etli CE3
genomic DNA (for primer sequences, see Fig. S1 in the supplemental
material). PCR products were inserted into plasmid pEX18Tc (26). Either
the gentamicin resistance cassette (Gm) from plasmid pUCGm (27) or the
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residues. Up to 4 mg of purified LPS was dissolved in 1.0 ml of glassdistilled water and incubated at 100°C for 10 min. Glacial acetic acid was
added to a concentration of 1%, and heating at 100°C was continued for
an additional 6 h. Lipid A was removed by extracting three times with 500
l of chloroform. The resulting aqueous phase, containing the O-antigen
and core regions, was dried. After methanolysis in methanolic 1 M HCl,
reaction with trimethylsilane, and extraction into hexane, the resulting
trimethylsilyl-methylglycosides were analyzed by gas chromatography on
an SPB-1 column (Supelco) (13). The oven temperature was raised 2°C
min⫺1 from 150 to 180°C, 1°C min⫺1 from 180 to 200°C, 5°C min⫺1 from
200 to 300°C, and then maintained at 300°C for 25 min. Identification of
GC peaks as particular sugars was confirmed by gas chromatography coupled to mass spectrometry (GC-MS) (data not shown).
Permeabilized cells and GDP-[3H]fucose labeling. Cells were grown
in TY medium to stationary phase, inoculated 1:20 into 50 ml of fresh TY
medium, and grown at 30°C for about 24 h. Cell growth was measured
(optical density at 595 nm [OD595] of ⬃0.5 to 0.6), and cells were collected
at 4,300 ⫻ g for 20 min. The cell pellet was washed once with 50 ml of 70
mM Tris (pH 8.2) and resuspended in a volume of 70 mM Tris containing
10 mM EDTA (pH 8.2) that gives a final cell concentration corresponding
to 100 times that of a suspension giving an OD595 of 1.0 (typically 250 to
280 l) (39, 40). The cell suspension was transferred to a 1.5-ml centrifuge
tube, and cells were frozen in a dry ice-ethanol bath and thawed in a 37°C
water bath a total of three times. The permeabilized cells were stored at
⫺80°C until use.
The standard reaction mixture (100 l) contained 70 l of permeabilized cells, 10 Ci of GDP-[3H]fucose (PerkinElmer; 0.1 mCi/ml, 15 to 35
Ci/mmol), 500 M UDP-N-acetylglucosamine, 500 M GDP-mannose,
and 100 M NADPH (39, 40). Reaction mixtures were incubated at 12°C
for 30 min and stopped by the addition of 0.5 ml of ice-cold 70 mM Tris
containing 10 mM EDTA (pH 8.2). After centrifugation, cell pellets were
washed twice with 0.3 ml of 70 mM Tris (pH 8.2) and extracted twice with
100 l of chloroform-methanol-water (1:2:0.3). The combined extracts
were dried in a vacuum centrifuge and resuspended in 10 l of the chloroform-methanol-water mixture. The entire volume was spotted on an
aluminum-backed precoated Silica-60 thin-layer chromatography (TLC)
plate and eluted in isobutyric acid–1.0 M ammonium hydroxide (5:3) for
8 h (41). The TLC plates were exposed to film at ⫺80°C.

RESULTS

The predicted glycosyltransferase ORFs and mutant constructions. The protein sequences encoded by ORFs wreG, wreH, wreL,
wreT, wreS, wreE, wreB, and the ␤ domain (17) of wreM (wreM␤)
within the O-antigen chromosomal genetic cluster and the wreU
ORF on endogenous plasmid pCFN42b of R. etli CE3 were each
predicted to contain a glycosyltransferase domain (see Fig. S2 in
the supplemental material). WreU best matched enzymes that
specifically transfer sugar phosphates, while the other eight proteins were similar to families of enzymes that transfer sugars from
sugar-nucleotide substrates.
Strains were constructed with mutations in each of the nine
predicted glycosyltransferase ORFs (Table 1 and Fig. 2; see Fig. S1
in the supplemental material). The approach was to insert antibiotic resistance cassettes that in past work have been shown to not
cause polar effects on genes downstream in an operon (17). Lack
of polarity was confirmed by complementation of the mutants to
the wild-type LPS phenotype when a plasmid carrying only the
wild-type allele corresponding to the mutated allele was transferred into a given mutant (Fig. S3). LPSs from these mutant
strains were analyzed by SDS-PAGE, immunoblotting, and examining the sugar composition.
SDS-PAGE. SDS-PAGE resolves the LPS of R. etli CE3 into two
distinct mobility classes (37), LPS I (containing the O antigen as
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kanamycin resistance cassette (Km) from plasmid pBSL15 (28) or plasmid pBSL86 (28) was inserted (Table 1).
Separately, plasmids carrying the mutated ORFs were transferred into
R. etli CE3 by triparental mating (32) with plasmid-mobilizer strain
MT616 (25) on TY agar plates. CE3 transconjugants containing these
constructs were selected and purified as previously described (17, 26).
Double-crossover recombinants were screened on TY agar plates supplemented with 1 g of tetracycline/ml. Of the recombinants that were sensitive to 1 g of tetracycline/ml and resistant to 8% sucrose on TY agar,
colonies were saved after verifying by PCR the absence of the wild-type
allele and the presence of a mutant allele. The resulting R. etli strains were
CE549 and CE547 (fcl), CE532 (lpcA), CE570 (wreH), CE518 (wreL),
CE551 and CE552 (wreS), CE522 (wreT), and CE566 (wreU) (Table 1).
Complementation of wre mutants with wild-type DNA. Wild-type
wre gene sequences were cloned separately into plasmid pFAJ1708 (29). A
recombinant plasmid carrying a particular wild-type gene was transferred
by triparental mating, as described above, into a strain mutated in that
particular gene. Transconjugants were selected on TY agar plates supplemented with 30 g of nalidixic acid/ml, 200 g of streptomycin/ml, 5 g
of tetracycline/ml, and 30 g of kanamycin/ml or 30 g of gentamicin/ml.
The presence of the respective wild-type gene restored wild-type LPS I, as
determined by SDS-PAGE (see Fig. S3 in the supplemental material).
SDS-PAGE analysis. Bacterial cells from 0.5-ml portions of fully
grown cultures were pelleted and extracted in 0.1 ml of 1⫻ SDS-PAGE
sample buffer (16) and treated with proteinase K (0.25 mg/ml) at 37°C for
1 h. After centrifugation to remove insoluble material, the SDS extracts
were subjected to electrophoresis by discontinuous Laemmli SDS-PAGE
(33) with 18% (wt/vol) acrylamide resolving minigels or by discontinuous
Tricine SDS-PAGE as described previously (34). LPS in the gels was
stained by a previously described periodate-silver method (35).
Immunoblot analysis with MAb. After SDS-PAGE, some minigels
were electrotransferred to nitrocellulose before periodate-silver staining
of the residual gel contents. The dried nitrocellulose blots were immunostained using monoclonal antibodies (MAb) JIM28 and JIM26 (generous
gifts from N. J. Brewin, Norwich, United Kingdom) (17, 36) and anti-rat
immunoglobulin M conjugated with alkaline phosphatase as previously
described (23, 36).
Purification of LPS. LPS was extracted from washed bacterial cell pellets (from 6.0 liters of culture) by the hot phenol-water method (PWE)
(37). LPS was then subjected to dialysis and treated with 0.05 mg/ml
RNase A, 15 units/ml DNase I, and 0.05 mg/ml proteinase K. After lyophilization, the LPS from the PWE aqueous phase was purified by gel filtration chromatography using a Sepharose 4B column with TEA-EDTA buffer (0.03 M triethylamine [TEA], 0.01 M EDTA [pH 7.0]), a Sepharose 4B
column with ammonium formate buffer (5.0 mM ammonium formate
[pH 5.0]), a Sephadex G-150 column with deoxycholic acid (DOC) buffer
(0.2 M NaCl, 1.0 mM EDTA, 10 mM Tris, 0.25% DOC) (16, 38), or a
Bio-Rad P-100 column with DOC buffer. The LPS content in fractions
eluted from the columns was assessed by SDS-PAGE of selected fractions.
The LPS-containing fractions were pooled, dialyzed against water, and
lyophilized. In the case of DOC buffer, the pooled fractions were dialyzed
first against DOC removal buffer (0.004 M Tris, 0.25% NaCl, 10% ethanol
[pH 9.3]) and second against water. The LPS from strains CE503 (17) and
CE566 was not subjected to purification by gel filtration, rather the PWE
aqueous phase was used for sugar composition analysis directly.
LPS compositions. For determination of neutral and amino sugars,
LPS preparations were treated with 2 M trifluoroacetic acid for 2 h at
121°C. After reduction with NaBD4 and acetylation, alditol acetate derivatives of the LPS sugars were analyzed by gas chromatography (GC) on a
fused silica capillary SP2300 column (60 m long; 0.53-mm inner diameter;
0.20-m film thickness) (Supelco) (13). The oven temperature was raised
1°C min⫺1 from 150 to 185°C, 10°C min⫺1 from 185 to 245°C, and then
maintained at 245°C for 35 min (35). For determination of glucuronic
acid and other acidic sugars, purified LPS was subjected to mild acid
hydrolysis to effect cleavage at 3-deoxy-D-manno-2-octulonic acid (Kdo)

Biosynthesis of the R. etli CE3 O Antigen

five repeat-unit domains, thereby conferring the major LPS I band in the wild type (WT) (lane 1). The less-abundant bands above and below this major band may
be due to O antigens having six and four repeat units, respectively. None of the glycosyltransferase mutants produced LPS I, and some synthesized truncated LPSs
of various sizes and abundances. The truncated LPSs of wreE and fcl mutants are visible above LPS II (small black arrowheads), while wreG and wreU mutants did
not produce a visible truncated LPS. The positions of LPS bands are indicated to the right of the gel as follows: I, LPS I; II, LPS II; T, truncated LPS. Lane 1, WT
(CE3); lane 2, wreL mutant (CE518); lane 3, wreM␤ mutant (CE542); lane 4, wreH mutant (CE570); lane 5, wreT mutant (CE522); lane 6, wreS mutant (CE551);
lane 7, wreE mutant (CE470); lane 8, wreG mutant (CE358); lane 9, wreU mutant (CE566); lane 10, wreE mutant (CE470); lane 11, fcl mutant (CE549); lane 12,
WT (CE3); lane 13, wreB mutant (CE503). Lanes 1 to 9, lanes 10 and 11, and lanes 12 and 13 are from gels run separately.

well as the lipid A and core regions) and LPS II (containing only
lipid A and core regions). All of the glycosyltransferase mutants
lacked the wild-type LPS I band, and several mutants synthesized
truncated LPS, which was usually less abundant than LPS I of the
wild type as indicated by silver staining (Fig. 3). wreU and wreG
mutants produced only LPS II and no visible, slower-moving
bands. On the other hand, wreE, wreS, wreT, and wreH mutants
gave rise to progressively longer versions of the O antigen, as inferred from the presence of progressively slower-migrating bands,
and wreM␤ and wreL mutants produced the slowest-moving
truncated LPSs. LPS I of the wreB mutant was produced in the
same abundance as the wild-type LPS I but exhibited a slightly
higher mobility (17).
The truncated LPS of the wreE mutant was compared to LPS
produced by mutants defective in the fcl and gmd genes. Because
Fcl and Gmd are required to convert GDP-mannose to GDPfucose (2, 42), mutants lacking either enzyme are expected to stop
O-antigen synthesis at the point fucose would be added. The truncated LPS of the wreE mutant was visible just above LPS II (Fig. 3,
small black arrowhead), and this same LPS profile was seen in fcl
and gmd mutants (Fig. 3, lane 11; also data not shown).
Antigenicity. Additional information about the mutant LPSs
was gained by probing immunoblots with monoclonal antibodies
(MAb) JIM26 and JIM28 (17, 36). Although truncated LPS was
resolved best by Tricine SDS-PAGE (Fig. 3), immunoblot staining
was much more sensitive after Laemmli-type SDS-PAGE (Fig. 4).
MAb JIM26 recognizes the R. etli CE3 O antigen (36) and bound
the truncated LPSs from wreB, wreM␤, wreL, wreT, wreH, and
wreS mutants (Fig. 4B and data not shown). MAb JIM28 specifically requires the R. etli CE3 O-antigen terminal residue as part of
its epitope (17, 43). Only the truncated LPS of the wreM␤ mutant
was bound by MAb JIM28, suggesting that the terminal residue
was present in the truncated O antigen of this strain (Fig. 4C).
Sugar compositions. The presence or absence of specific Oantigen sugars was investigated by sugar composition analysis of
purified mutant LPSs (Table 2). As indicated on SDS-polyacrylamide gels (Fig. 3 and 4), the amount of the O-antigen sugars
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contributed by the truncated LPSs would be low compared to the
amount of sugars of the wild-type LPS I and LPS II. To ensure that
background noise or contamination was not mistaken as a low
level of a given sugar in a mutant, an lpcA mutant was constructed
(Table 1) and included as a negative control. In lpcA mutants, the
galactose of the core region is not attached (44); thus, the O antigen cannot be attached to the truncated core, and the LPS of this
mutant should lack the O-antigen sugars entirely (Table 2).
The wreB mutant contained all the O-antigen sugars in wild-

FIG 4 MAb binding to truncated LPSs from mutants with lesions in genes
encoding the nine predicted glycosyltransferases. (A) 18% Laemmli SDS-polyacrylamide gel with LPS stained by silver-periodate. (B and C) LPS material
from the gel shown in panel A was transferred to nitrocellulose and probed
with MAb JIM26 (B) or MAb JIM28 (C). Lane 1, wreU mutant (CE113); lane
2, wreG mutant (CE358); lane 3, wreE mutant (CE470); lane 4, wreS mutant
(CE551); lane 5, wreL mutant (CE518); lane 6, wreT mutant (CE522); lane 7,
wreM␤ mutant (CE542); lane 8, wreB mutant (CE503); lane 9, WT (CE3). The
positions of LPS bands are indicated to the right of the gel as follows: I, LPS I;
T, truncated LPS; II, LPS II.
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FIG 3 Tricine SDS-PAGE of LPSs from mutants with lesions in the genes encoding the nine predicted glycosyltransferases. The O antigen on average consists of
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TABLE 2 O-antigen sugar contents relative to two core sugars in the
mutantsa
Strain or
mutantb

Relative content of sugarc
Fuc

3OMe6dTal

GlcA

MexFuc

Man

Gal

WT
wreU
wreG
fcl
wreE
wreS
wreT
wreH
wreL
wreM␤
wreB

0.47
NDd
0.031
0.014
0.013
0.010
0.030
0.025
0.018
0.027
0.41

2.67
ND
ND
ND
ND
0.021
0.142
0.115
0.091
0.086
2.77

2.62
ND
ND
ND
ND
ND
ND
0.020
0.011
0.032
2.08

2.85
NTe
NT
NT
0.021
0.018
0.056
0.029
0.092
0.083
2.72

0.63
ND
ND
ND
ND
ND
ND
ND
ND
0.05
ND

1.53
1.04
0.95
1.01
0.94
0.92
1.01
0.91
1.33
1.21
1.47

1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00

lpcA

ND

0.002

ND

0.018

ND

1.00

0.03

a

The GC peak areas were used directly to calculate the relative content of each sugar
normalized to the GC peak area of Gal. The values for the negative-control lpcA mutant
were normalized to mannose, because the lpcA mutation blocks LPS core synthesis
before the addition of galactose. The internal standard sugar, Gal or Man, was set to a
value of 1.00 to reflect its molar amount in the LPS core. Neutral and amino sugar
compositions were determined as alditol acetates after acid hydrolysis of purified LPSs.
GlcA contents were determined from separate analysis after mild acid hydrolysis,
removal of lipid A, and conversion of sugars to trimethylsilyl-methylglycoside
derivatives.
b
The strains were as follows: WT, CE3; wreU, CE113; wreG, CE358; wreE, CE470; fcl,
CE549; wreS, CE551; wreT, CE522; wreL, CE518; wreM␤, CE542; wreB, CE503; and
lpcA, CE532. Analysis of LPS from the wreU mutant strain CE566 exhibits the same
absence of O-antigen sugars as in strain CE113 (data not shown).
c
Abbreviations for O-antigen-specific sugars: QuiN, quinovosamine; Fuc, fucose;
3OMe6dTal, 3-O-methyl-6-deoxytalose; GlcA, glucuronic acid; MexFuc, di-Omethylfucose and tri-O-methylfucose. Abbreviations for core sugars: Man, mannose;
Gal, galactose. Man is present in both the O antigen and the core, but its presence in the
mutant LPSs is overwhelmingly due to LPS II.
d
ND, not detected (i.e., ⱕ0.001 relative content of the sugar, normalized to galactose).
e
NT, not tested.

type amounts except the terminal residue, as previously reported
(17). Conversely, wreU mutants had undetectable levels of any
O-antigen-specific sugar, including quinovosamine (QuiN) (Table 2). The other seven predicted glycosyltransferase mutants had
low but detectable levels of QuiN, which correlated with the low
abundance of their truncated LPS on gels. Mannose was present in
all mutant LPSs, because it is a component of the core region (45);
thus, a minor amount of mannose contributed by a truncated O
antigen could not be distinguished from mannose contributed by
the core region. Of those mutant LPSs that contained QuiN, fucose was detected in the truncated LPSs from wreS, wreT, wreH,
wreM␤, and wreL mutants, whereas it was not detected in wreG
and wreE mutants. Furthermore, consistent with the O-antigen
structure (Fig. 1), mutant LPSs that lacked QuiN (lpcA and wreU
mutants) also lacked detectable levels of fucose. For LPSs that
contained fucose, there was the potential to contain the rest of the
O-antigen sugars. LPSs from the wreH, wreM␤, and wreL mutants
contained 3OMe6dTal, whereas this sugar was not detected in the
LPSs from the wreS and wreT mutants. Only wreM␤ mutants contained detectable levels of the terminal residue (Table 2), in accord
with the binding of its truncated LPS to MAb JIM28 (Fig. 4C).
There appeared to be a low, background level of glucuronic
acid (GlcA) in all LPS preparations, even from the negative-control lpcA mutant. This GlcA contamination was not due to reagents, and it was not found in rinses of the column matrices.
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DISCUSSION

In this study, nine ORFs predicted to encode glycosyltransferases
were analyzed and determined to be necessary for the synthesis of
the Rhizobium etli CE3 O antigen. None of these predicted enzymes have been tested by an activity assay; however, amino acid
similarities with these particular glycosyltransferase families have
tended to be valid predictions of function (46, 47). Together, the
mutagenesis experiments suggest that O-antigen biosynthesis initiates with the activity of WreU and requires the sequential glycosyltransferase activities of WreG, WreE, WreS, WreT, WreH,
WreM␤, WreL, and WreB (Fig. 6). The arguments for these proposed assignments are presented below.

FIG 5 In vitro labeling of permeabilized cells with GDP-[3H]fucose. Permeabilized cells were incubated with GDP-[3H]fucose, and the resulting labeled
molecules were extracted with chloroform-methanol-water (1:2:0.3), separated by TLC in the isobutyric acid–1.0 M ammonium hydroxide (5:3) solvent
(39–41), and visualized by fluorography. A metabolite labeled with radioactive
fucose that is present in the wreS mutant and absent in the wreE mutant is
shown by a box around the relevant part of the gel. The positions of unincorporated GDP-fucose (black arrow) and fucose (small black arrowhead) are
also indicated. Lane 1, wreS mutant (CE551); lane 2, wreE mutant (CE470).
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QuiN

Mutant strains not expected to have GlcA—wreE, wreS, and lpcA
mutants-– had a fairly uniform amount of GlcA relative to the
core sugars. GlcA in the wreH mutant was at or very close to this
background level, but three mutants appeared to have relative
amounts indicating true GlcA contents in their truncated LPSs,
with the relative values in wreL and wreM␤ mutant LPS preparations being significantly higher than in the wreT mutant LPS preparations (Table 2).
Incorporation of [3H]fucose into the truncated LPSs from
wreE and wreS mutants. Of the sugars that may be unique to the
R. etli CE3 O antigen (Fig. 1), only fucose is available commercially as the radioisotope-labeled portion of a nucleotide sugar
(GDP-fucose in this case). This allows an alternative approach to
demonstrate whether LPS from the wreS mutant differs from LPS
from the wreE mutant by having a fucose residue. Cells of each
strain were permeabilized and incubated with GDP-[3H]fucose.
Separation of the resulting fucose-labeled molecules by TLC revealed a band unique to the wreS mutant (Fig. 5), consistent with
the presence of fucose in the truncated LPS of the wreS mutant and
the absence of fucose in the truncated LPS of the wreE mutant.

Biosynthesis of the R. etli CE3 O Antigen

QuiNAc as the primer and WreU as the catalyst for its addition to BpP. Most of the mutants constructed in this study produced LPS with severely truncated O antigens, and the amount of
the truncated LPS was severely decreased in these mutants relative
to wild-type O-antigen-containing LPS I (Fig. 3). Thus, in the
total LPS from any of these mutants, any O-antigen-specific sugar
was present in a small amount relative to that of the core-specific
sugars. As sugar analysis showed, QuiN was one of the sugars
present in much smaller amounts than the known core sugars
(Table 2). Previous chemical/genetic studies (48) indicated that
QuiNAc was linked to a Kdo residue (Fig. 1), and biosynthetic/
genetic studies (44, 45, 49, 50) provide strong evidence that this
Kdo is part of the biosynthetic core of the LPS. It follows from our
composition data and these previous conclusions that QuiNAc
not only is part of the O antigen but is the first sugar added in
O-antigen synthesis.
Based on sequence and mutation analyses in this study, the
wreU gene likely encodes the glycosyltransferase that initiates
O-antigen synthesis. The predicted protein sequence of WreU
(188 amino acids [aa]) is annotated as a prenyl-phosphatesugar-phosphotransferase (see Fig. S2 in the supplemental material), the type of reaction generally required for the initial
reaction of O-antigen synthesis (1). In Salmonella enterica,
WbaP (476 aa) is the initiator of O-antigen synthesis, where the
C-terminal half of the protein functions as the undecaprenylphosphate-galactosephosphotransferase (5, 51). Alignment of
the C-terminal portion of WbaP (aa 290 to 476) and WreU (aa
16 to 188) revealed a high degree of similarity between the
protein sequences, including the relative location of a predicted transmembrane domain and putative binding sites for
sugar nucleotides and prenyl-phosphate substrates (5) (data
not shown). Like WbaP-deficient strains, mutants defective in
wreU (strains CE113 and CE566) produced LPS lacking all Oantigen-specific sugars, including QuiN (Table 2). Thus, it is
proposed that WreU transfers QuiNAc-1-phosphate to the BpP
lipid carrier, thereby initiating O-antigen biosynthesis in R.
etli CE3.
Addition of sugars of the adaptor region by WreG, WreE,
WreS, and WreT. Because all mutant LPS samples had a large
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proportion of LPS II, which contains mannose, sugar composition
data did not definitively identify the particular mutant unable to
add mannose to QuiNAc. Mutants defective in either one of two
glycosyltransferase genes, wreG or wreE, produced LPS containing
QuiN but lacking fucose (Table 2). Differences between the two
strains were revealed by Tricine SDS-PAGE (Fig. 3). The wreE
mutant produced an LPS of low abundance whose mobility was
barely resolved from that of LPS II, whereas any truncated LPS
produced by the wreG mutant was not resolved from LPS II. This
result suggests a shorter O antigen in the wreG mutant. Furthermore, the LPS profile of the wreE mutant on Tricine SDS-polyacrylamide gels was identical to those of fcl mutants, which as
expected also lacked fucose. All of these data support the assignment of WreG as the glycosyltransferase responsible for the addition of mannose and WreE for the addition of the first fucose
(FucI).
Arguments stated in the introduction predict that the additions of the first two fucose residues (FucI and FucII) of the O
antigen require two different glycosyltransferases. The wreS mutant produces a truncated LPS whose mobility is lower than that of
the wreE mutant (Fig. 3), suggesting an O antigen having another
sugar residue after QuiNAc and mannose. Supporting this inference is the presence of fucose in composition analysis and the
ability to incorporate [3H]fucose into the truncated LPS of the
wreS mutant (Table 2 and Fig. 5), implicating WreS as the glycosyltransferase for the second fucose (FucII). Interestingly, the
genes proposed to be involved in the synthesis of GDP-fucose
(gmd and fcl) and the attachment of the first two fucose residues
(wreE and wreS) are located consecutively in the chromosomal
genetic cluster (Fig. 2A).
After two fucose residues have been added, the next glycosyltransferase would catalyze the addition of either MeGlcA or
3OMe6dTal. The wreT mutant produced the next fastest-moving
truncated LPS, which was found to contain QuiN and contain
twice as much fucose/QuiN as the wreS mutant but lack
3OMe6dTal (Fig. 3 and Table 2). Because all of the other mutants
not considered yet (wreH, wreM␤, and wreL mutants) do have
3OMe6dTal, it is proposed that this residue is added after the
second fucose and that WreT is the responsible enzyme. In order
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FIG 6 R. etli CE3 O-antigen biosynthesis model. Current data indicate a synthesis model in which WreU attaches N-acetyl-quinovosamine-1-phosphate
(QuiNAc) to bactoprenol phosphate (BpP); WreG attaches mannose (Man) to QuiNAc; WreE attaches the first fucose (FucI); WreS attaches the fucose in the first
instance of the repeating unit (FucII); WreM␤ attaches the fucoses of the second, third, fourth, and fifth repeating units (FucIII–VI); WreT attaches the
3-O-methyl-6-deoxytalose (3OMe6dTal) in the first instance of the repeating unit; WreL attaches 3OMe6dTal of the remaining repeating units; WreH attaches
the methyl glucuronate (MeGlcA) of each repeating unit; and WreB attaches the terminal residue. Abbreviation: P-P-Bp, bactoprenol pyrophosphate.
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mutant likely cannot extend the O antigen beyond the sugars of
the first repeating unit. Thus, the fucose residues of the second,
third, fourth, and fifth repeating units (FucIII-VI) are added by the
WreM␤ glycosyltransferase.
The truncated LPS from the wreL mutant was the slowest moving LPS on the SDS-polyacrylamide gel (Fig. 3), thereby implicating WreL as the next glycosyltransferase to act in O-antigen synthesis. Considering the high similarity in protein sequence
between WreL and WreT (data not shown), it is a logical possibility that WreT adds 3OMe6dTal to the first repeat unit and WreL
adds this sugar to the subsequent repeat units. LPS sugar compositions are consistent with this conclusion: LPS produced by the
wreL mutant contained the same neutral and amino sugars as LPS
produced by the wreH mutant, the fucose/QuiN ratio from the
data in Table 2 is at least as high as that of the wreH mutant, and
the net GlcA/QuiN ratio is much higher in the wreL mutant than
in the wreH mutant. Consideration of these results, as well as the
deduced activities of the other predicted glycosyltransferases, leads to
the assignment of the role of WreL being the one indicated in Fig. 6.
This assignment completes the set of activities needed to link the
sugars together to obtain the R. etli CE3 O-antigen structure that has
been determined by chemical analysis (13) (Fig. 1 and 6).
Significance of the low abundance of truncated LPSs. SDSPAGE is a common approach to identifying mutants defective in
genes required for the biosynthesis of the core and O-antigen regions of LPS (52–55). Such analysis in R. etli reveals a set of mutants producing stepwise truncations in the O antigen that, as
noted above, greatly aid in deducing functional assignments of
glycosyltransferases for each discrete step in O-antigen synthesis.
However, all of the glycosyltransferase mutants, with the exception of the wreB mutant, produce a truncated LPS in much less
abundance than LPS I of the wild type (Fig. 3). One possible explanation is that the wild-type glycosyltransferase enzymes form
multisubunit O-antigen-synthesizing complexes, and the rate of
synthesis is reduced when the remaining enzymes cannot form
optimal complexes. Alternatively, the truncated O antigens may
not be ideal substrates for the ABC transporter or the O-antigen
ligase, such that the truncated O antigens are not readily translocated across the inner membrane and/or attached to the core and
lipid A regions, respectively.
Summary. It is important to determine O-antigen structures
and understand their biosynthesis because of their central role in
mutualistic symbioses (e.g., Rhizobium [2, 16, 56, 57]) and pathogenic symbioses (58, 59). This study has identified nine putative
glycosyltransferase genes within the known O-antigen genetic regions, created mutants with defects in each gene, performed analyses on the resulting mutant LPSs, and demonstrated each predicted glycosyltransferase to have a role in O-antigen synthesis.
The data support a model (Fig. 6) specifying the respective function of each predicted glycosyltransferase. It is a working hypothesis that may not be correct in all respects, but all assignments are
based on evidence that is fully consistent with the assignments.
The value of the model is that it is comprehensive and makes
specific predictions of biosynthetic activities to be tested in future
experiments.
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to add 3OMe6dTal to the second fucose and not to the first one, it
seems likely that this enzyme has a stringent requirement that the
acceptor substrate has two fucose residues. As mentioned in the
introduction, this would be the only point in the synthesis of this
O antigen that an enzyme with this specificity could act. Hence, in
terms of the biosynthetic mechanism, this first 3OMe6dTal is proposed to be the last residue of the adaptor region of the R. etli CE3
O antigen.
Addition of repeat-unit sugars by WreH, WreM␤, and WreL.
If the repeat unit is constructed by first adding 3OMe6dTal to the
second fucose residue, the next step must be the addition of
MeGlcA (Fig. 1) (or possibly GlcA before it is methylated). Using
mobility on SDS-polyacrylamide gels as an indication of relative
LPS length, the wreH mutant produced a truncated LPS larger
than that of the wreT mutant and smaller than that of the wreM␤
or wreL mutant (Fig. 3). WreH is therefore proposed as the glycosyltransferase that acts next after WreT. In support of this assignment, sugar analysis showed the presence of QuiN, fucose, and
3OMe6dTal in the truncated LPS of this strain (Table 2). Also
consistent with this assignment is the fact that, in the wreH mutant
LPS, GlcA content was at or barely above the background amount
observed from mutants that should have no GlcA, such as wreE,
wreS, and lpcA mutants. On the other hand, a considerably higher
content of GlcA above this background was detected in the wreT
mutant. A likely explanation is that while the WreH enzyme uses
the first 3OMe6dTal residue as part of its substrate recognition
and is therefore mainly blocked in the wreT mutant, WreH can
link MeGlcA to FucII at very low efficiency in the absence of
3OMe6dTal. Indeed, when purified wreT mutant LPS was overloaded on Tricine-SDS gels, a closely spaced ladder of bands that
stained less and less intensely as size increased could be observed
(Fig. 3 and data not shown). These bands would be consistent with
very small amounts of O antigen having variable numbers of
MeGlcA-Fuc- repeats. All of these considerations make it most
likely that WreH is the glycosyltransferase that attaches MeGlcA as
shown in Fig. 6.
The first fucose (FucI) is attached by a 1,3-linkage to ␤-D-mannose, the fucose of the first repeat unit (FucII) is linked by a 1,3linkage to the first ␣-L-fucose, and the fucose of the second, third,
fourth, and fifth repeat units (FucIII-VI) is transferred to ␣-DMeGlcA of the previous repeat unit by a 1,4-linkage (Fig. 1) (2,
13). Due to these different acceptor substrates and linkages, it is
expected that the addition of fucose in the latter repeating units
(FucIII-VI) requires a glycosyltransferase other than WreE or WreS.
The wreM␤ mutant produced one of the slowest-moving truncated LPSs (Fig. 3), and it contained detectable amounts of all the
O-antigen sugars, including the terminal residue (Fig. 4C and Table 2). In order for the terminal residue to be present, the residue
to which it is normally attached (MeGlcA) is also presumed to be
present. Apparently, in the absence of further elongation in this
mutant, the terminal residue can be attached, which is the function of WreB as previously reported (17). Interestingly, it appears
that the truncated O antigen, consisting of one repeat unit, does
not serve as an optimal substrate for WreB because the terminal
residue is not attached to all truncated O antigens produced by the
wreM␤ mutant, which explains the presence of the double-band
pattern seen on Tricine gels and the relatively small amount of this
sugar in composition data (Fig. 3 and Table 2). The capability to
attach the terminal residue, combined with the observation that
the wreM␤ defect results in a truncated LPS, implies that this

Biosynthesis of the R. etli CE3 O Antigen

tagenesis and strain isolations. We thank H. P. Schweizer and M. F. Alexeyev for plasmids.
This work was supported by grants DE-FG02-98ER-20307 from the
U.S. Department of Energy and 1 R15 GM087699-01A1 from the National Institutes of Health. K.J.O. was supported in part by predoctoral
fellowships from the A. J. Schmitt Foundation and the U.S. Department of
Education Graduate Assistance in the Areas of National Need program.

REFERENCES

May 2013 Volume 195 Number 9

22.
23.
24.
25.
26.

27.
28.
29.
30.
31.
32.
33.
34.

35.

36.
37.

38.

39.
40.
41.
42.

43.
44.

jb.asm.org 1957

Downloaded from http://jb.asm.org/ on January 23, 2014 by Marquette University Libraries

1. Raetz CR, Whitfield C. 2002. Lipopolysaccharide endotoxins. Annu. Rev.
Biochem. 71:635–700.
2. Carlson RW, Forsberg LS, Kannenberg EL. 2010. Lipopolysaccharide in
Rhizobium-legume symbioses. Subcell. Biochem. 53:339 –386.
3. El Ghachi M, Bouhss A, Blanot D, Mengin-Lecreulx D. 2004. The bacA
gene of Escherichia coli encodes an undecaprenyl pyrophosphate phosphatase activity. J. Biol. Chem. 279:30106 –30113.
4. Vinogradov E, Frirdich E, MacLean LL, Perry MB, Petersen BO, Duus
JO, Whitfield C. 2002. Structures of lipopolysaccharides from Klebsiella
pneumoniae. J. Biol. Chem. 277:25070 –25081.
5. Wang L, Liu D, Reeves PR. 1996. C-terminal half of Salmonella enterica
WbaP (RfbP) is the galactosyl-1-phosphate transferase domain catalyzing
the first step of O-antigen synthesis. J. Bacteriol. 178:2598 –2604.
6. Flemming H, Jann K. 1978. Biosynthesis of the O9 antigen of Escherichia
coli: growth of the polysaccharide chain. Eur. J. Biochem. 83:47–52.
7. Reizer J, Reizer A, Saier MHJ. 1992. A new subfamily of bacterial ABCtype transport system catalyzing export of drugs and carbohydrates. Protein Sci. 1:1326 –1332.
8. Samuel G, Reeves P. 2003. Biosynthesis of O-antigens: genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr. Res. 338:2503–2519.
9. Mulford CA, Osborn MJ. 1983. An intermediate step in translocation of
lipopolysaccharide to the outer membrane of Salmonella typhimurium.
Proc. Natl. Acad. Sci. U. S. A. 80:1159 –1163.
10. Raetz CRH, Reynolds CM, Trent MS, Bishop RE. 2007. Lipid A modification systems in Gram-negative bacteria. Annu. Rev. Biochem. 76:295–
329.
11. Liechti G, Goldberg JB. 2012. Outer membrane biogenesis in Escherichia
coli, Neisseria meningitidis, and Helicobacter pylori: paradigm deviations in
H. pylori. Front. Cell. Infect. Microbiol. 29:1–18.
12. Sperandeo P, Dehò G, Polissi A. 2009. The lipopolysaccharide transport
system of Gram-negative bacteria. Biochim. Biophys. Acta 1791:594 – 602.
13. Forsberg LS, Bhat RU, Carlson RW. 2000. Structural characterization of
the O-antigenic polysaccharide of the lipopolysaccharide from Rhizobium
etli strain CE3. J. Biol. Chem. 275:18851–18863.
14. Gonzalez V, Santamaria RI, Bustos P, Hernandez-Gonzalez I, Medrano-Soto A, Moreno-Hagelsieb G, Janga SC, Ramirez MA, JimenezJacinto V, Collado-Vides J, Davila G. 2006. The partitioned Rhizobium
etli genome: genetic and metabolic redundancy in seven interacting replicons. Proc. Natl. Acad. Sci. U. S. A. 103:3834 –3839.
15. Lerouge I, Laeremans T, Verreth C, Vanderleyden J, Van Soom C,
Tobin A, Carlson RW. 2001. Identification of an ATP-binding cassette
transporter for export of the O-antigen across the inner membrane in
Rhizobium etli based on the genetic, functional, and structural analysis of
an LPS mutant deficient in O-antigen. J. Biol. Chem. 276:17190 –17198.
16. Cava JR, Elias PM, Turowski DA, Noel KD. 1989. Rhizobium leguminosarum CFN42 genetic regions encoding lipopolysaccharide structures essential for complete nodule development on bean plants. J. Bacteriol. 171:
8 –15.
17. Ojeda KJ, Box JM, Noel KD. 2010. Genetic basis for Rhizobium etli CE3
O antigen O-methylated residues that vary according to growth conditions. J. Bacteriol. 192:679 – 690.
18. Reeves PR, Hobbs M, Valvan MA, Skurnik M, Whitfield C, Coplin D,
Kido N, Klena J, Maskell D, Raetz CRH, Rick PD. 1996. Bacterial
polysaccharide synthesis and gene nomenclature. Trends Microbiol.
4:495–503.
19. Garcia de los Santos A, Brom S. 1997. Characterization of two plasmidborne lps beta loci of Rhizobium etli required for lipopolysaccharide synthesis and for optimal interaction with plants. Mol. Plant Microbe Interact. 7:891–902.
20. Forsberg LS, Noel KD, Box J, Carlson RW. 2003. Genetic locus and
structural characterization of the biochemical defect in the O-antigenic

21.

polysaccharide of the symbiotically deficient Rhizobium etli mutant,
CE166. J. Biol. Chem. 278:51347–51359.
Lerouge I, Verreth C, Michiels J, Carlson RW, Datta A, Gao MY,
Vanderleyden J. 2003. Three genes encoding for putative methyl- and
acetyltransferases map adjacent to the wzm and wzt genes and are essential
for O-antigen biosynthesis in Rhizobium etli CE3. Mol. Plant Microbe
Interact. 16:1085–1093.
Noel KD, Sanchez A, Fernandez L, Leemans J, Cevallos MA. 1984.
Rhizobium phaseoli symbiotic mutants with transposon Tn5 insertions. J.
Bacteriol. 158:148 –155.
Tao H, Brewin NJ, Noel KD. 1992. Rhizobium leguminosarum CFN42
lipopolysaccharide antigenic changes induced by environmental conditions. J. Bacteriol. 174:2222–2229.
Benziger L. 2002. M.S. thesis. Marquette University, Milwaukee, WI.
Finan TM, Kunkel B, De Vos GF, Signer ER. 1986. Second symbiotic
megaplasmid in Rhizobium meliloti carrying exopolysaccharide and thiamine synthesis genes. J. Bacteriol. 167:66 –72.
Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. 1998.
A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation
of unmarked Pseudomonas aeruginosa mutants. Gene 212:77– 89.
Schweizer HP. 1993. Small broad-host-range gentamycin resistance gene
cassettes for site-specific insertion and deletion mutagenesis. Biotechniques 15:831– 833.
Alexeyev MF. 1995. Three kanamycin resistance gene cassettes with different polylinkers. Biotechniques 18:52–56.
Dombrecht B, Vanderleyden J, Michiels J. 2001. Stable RK2-derived
cloning vectors for the analysis of gene expression and gene function in
Gram-negative bacteria. Mol. Plant Microbe Interact. 14:426 – 430.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic
Local Alignment Search Tool. J. Mol. Biol. 215:403– 410.
Hanahan D. 1983. Studies on transformation of Escherichia coli with
plasmids. J. Mol. Biol. 166:557–580.
Glazebrook J, Walker GC. 1991. Genetic techniques in Rhizobium meliloti. Methods Enzymol. 204:398 – 418.
Laemmli UK. 1970. Cleavage of structural proteins during the assembly of
the head of bacteriophage T4. Nature 227:680 – 685.
Lesse AJ, Campagnari AA, Bittner WE, Apicella MA. 1990. Increased
resolution of lipopolysaccharides and lipooligosaccharides utilizing Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis J. Immunol. Methods 126:109 –117.
Noel KD, Box JM, Bonne VJ. 2004. 2-O-Methylation of fucosyl residues
of a rhizobial lipopolysaccharide is increased in response to host exudate
and is eliminated in a symbiotically defective mutant. Appl. Environ. Microbiol. 70:1537–1544.
Noel KD, Duelli DM, Tao H, Brewin NJ. 1996. Antigenic change in the
lipopolysaccharide of Rhizobium etli CFN42 induced by exudates of
Phaseolus vulgaris. Mol. Plant Microbe Interact. 9:180 –186.
Carlson RW, Kalembasa S, Turowski D, Pachori P, Noel KD. 1987.
Characterization of the lipopolysaccharide from a Rhizobium phaseoli mutant that is defective in infection thread development. J. Bacteriol. 169:
4923– 4928.
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